Both in Pharmaceuticals
Keros Therapeutics vs Nature's Sunshine Products
Over the past year KROS returned −29.8% and NATR returned −16.1%; their daily moves had a correlation of 0.12.
KROS −29.8% NATR −16.1%Growth of $1, one year, split-adjusted
| Metric | KROS | NATR |
|---|---|---|
| Price | $11.19 | $12.76 |
| Market cap | $221.9M | $224.5M |
| Today | −0.80% | −0.55% |
| 1 month | +1.5% | −10.2% |
| 6 months | +4.8% | −47.1% |
| Year to date | −45.0% | −40.9% |
| 1 year | −30.3% | −19.7% |
| Revenue growth (YoY) | −100.0% | +1.9% |
| Gross margin | — | 73.7% |
| Net margin | — | 3.0% |
| P/E (TTM) | — | 12.4× |
| Price / sales | 14.8× | 0.5× |
| Net cash | $257.6M | $82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 48.2% | 51.6% |
| Short % of float | 7.3% | 5.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).